Renaissance Technologies (RenTech)'s TNGX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 748,300 shares of Tango Therapeutics, Inc. (TNGX) worth $23.39 M, representing 0.03% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in TNGX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 748,300 shares. Largest reduction occurred in Q2 2025, reducing 109,000 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Tango Therapeutics (TNGX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tango Therapeutics (TNGX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +748,300 | New Buy | 748,300 | $31.26 |
| Q4 2025 | -55,300 | Sold Out | 0 | $0.00 |
| Q3 2025 | -10,200 | Reduce 15.57% | 55,300 | $8.40 |
| Q2 2025 | -109,000 | Reduce 62.46% | 65,500 | $5.12 |
| Q1 2025 | +153,000 | Add 711.63% | 174,500 | $1.37 |
| Q4 2024 | +21,500 | New Buy | 21,500 | $3.09 |
| Q2 2024 | -65,600 | Sold Out | 0 | $0.00 |
| Q1 2024 | -55,400 | Reduce 45.79% | 65,600 | $7.94 |
| Q4 2023 | +82,800 | Add 216.75% | 121,000 | $9.90 |
| Q3 2023 | -40,500 | Reduce 51.46% | 38,200 | $11.26 |
| Q2 2023 | +17,800 | Add 29.23% | 78,700 | $0.00 |
| Q1 2023 | +35,600 | Add 140.71% | 60,900 | $0.00 |
| Q4 2022 | +14,100 | Add 125.89% | 25,300 | $0.01 |
| Q3 2022 | +11,200 | New Buy | 11,200 | $3.66 |
Renaissance Technologies (RenTech)'s Tango Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Tango Therapeutics, Inc. (TNGX) in Q3 2022, acquiring 11,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Tango Therapeutics, Inc. (TNGX) for 14 quarters since Q3 2022.
Renaissance Technologies (RenTech)'s largest addition to Tango Therapeutics, Inc. (TNGX) was in Q2 2026, adding 748,300 shares worth $23.39 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 748,300 shares of Tango Therapeutics, Inc. (TNGX), valued at approximately $23.39 M.
As of the Q2 2026 filing, Tango Therapeutics, Inc. (TNGX) represents approximately 0.03% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Tango Therapeutics, Inc. (TNGX) was 748,300 shares, as reported at the end of Q2 2026.